Galenica AG
GALE
Rang in Aktien
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Aktienkurs
$108.43
Marktkapitalisierung
$5.40B
Veränderung (1 Tag)
1.19%
Veränderung (1 Jahr)
-3.89%
Land
CH
Handel Galenica AG (GALE)
Kategorie
Healthcare
Gewinn für Galenica AG (GALE)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Galenica AG betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Galenica AG von 2014 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2025 | $280.22M | 17.95% |
| 2024 | $237.57M | 2.48% |
| 2023 | $231.81M | 9.67% |
| 2022 | $211.38M | -1.81% |
| 2021 | $215.28M | -5.25% |
| 2020 | $227.21M | 34.53% |
| 2019 | $168.90M | 49.81% |
| 2018 | $112.74M | -21.46% |
| 2017 | $143.55M | 40.14% |
| 2016 | $102.44M | 2.77% |
| 2015 | $99.67M | 1.17% |
| 2014 | $98.52M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $6.46B | - |
US
|
|
| - | - |
US
|
|
| $2.17B | - |
US
|
|
| - | - |
US
|
|
| $708.86M | - |
AU
|
